Vousden K H, Eccles S A, Purvies H, Marshall C J
Int J Cancer. 1986 Mar 15;37(3):425-33. doi: 10.1002/ijc.2910370315.
To investigate whether the presence of an activated ras oncogene influences the ability of tumour cells to metastasize, the c-Ha-ras-1 oncogene cloned from EJ/T24 cells was introduced into MT1 Cl.5/7 mouse mammary carcinoma cells. Since the MT1 Cl.5/7 cells are already tumorigenic but have a low metastatic capacity, this experimental design allows a distinction to be made between the effects of the ras gene on metastasis and tumorigenicity. MT1 Cl.5/7 containing the EJ c-Ha-ras-1 metastasized more readily and to more tissue sites than control cells (2.8 sites/mouse vs 0.9 sites/mouse). The metastases expressed the EJ c-Ha-ras-1 p21 ras proteins; however, one metastasis was discovered that had lost the expression of the c-Ha-ras-1 gene. When these cells were re-tested for metastasis, the rate of metastasis was indistinguishable from that of controls. This observation, coupled with a demonstration that lung colonization potential following intravenous inoculation is unaffected by the presence of the activated ras gene, argues that the effect of mutant ras genes is exerted on the ability of cells to escape from the primary tumour, rather than on a survival in the circulatory systems and ability to seed a second site.
为了研究激活的ras癌基因的存在是否会影响肿瘤细胞的转移能力,将从EJ/T24细胞克隆的c-Ha-ras-1癌基因导入MT1 Cl.5/7小鼠乳腺癌细胞。由于MT1 Cl.5/7细胞已经具有致瘤性,但转移能力较低,这种实验设计能够区分ras基因对转移和致瘤性的影响。含有EJ c-Ha-ras-1的MT1 Cl.5/7细胞比对照细胞更容易发生转移,且转移到更多的组织部位(2.8个部位/小鼠对0.9个部位/小鼠)。转移灶表达EJ c-Ha-ras-1 p21 ras蛋白;然而,发现一个转移灶失去了c-Ha-ras-1基因的表达。当对这些细胞重新进行转移测试时,转移率与对照无差异。这一观察结果,再加上静脉接种后肺定植潜能不受激活的ras基因存在影响的证明,表明突变ras基因的作用是施加于细胞从原发肿瘤逃逸的能力上,而不是对其在循环系统中的存活和在第二个部位定植的能力。